1992. Shenzhen Huakang was established in the PRC

2004. We started the research and development of male fertility IVD reagents.

2005. We expanded our production scale and established a production plant at No.4th Taifeng Industrial Zone, Xuegang, Shajing, Bao’an District, Shenzhen (深圳市寶安區沙井壆崗泰豐工業區4號). Our project in relation to the research and development of male fertility test kits (男性不育實驗診斷試劑盒系列的研究與開發項目) was awarded Third Class Prize of Scientific Progress (科學進步三等獎) by Shenzhen Municipal People’s Government (深圳市人民政府).

2007. Our EBV antibody detection reagent obtained the first product registration certificate from CFDA.

2008. Our male fertility IVD reagent obtained the first product registration certificate from CFDA and was commercially launched in the PRC. Our EBV antibody detection reagent was commercially launched in the PRC.

2011. Our project in relation to the recombinant expression of EB virus antigen epitope and development of the new generation of diagnostic reagents for nasopharyngeal carcinoma (EB病毒抗原表位元重組及新一代鼻咽癌診斷試劑研製項目) was awarded Third Class Prize of Science and Technology of Guangdong Province (廣東省科學技術三等獎) by the People’s Government of Guangdong Province (廣東省人民政府). Our products seminal plasma neutral alpha-glucosidase quantitative assay kit (精漿中性α-葡糖苷酶定量檢測試劑盒) and spermatozoan surface antibody IgG mixed agglutination reaction kit (精子膜表面抗體IgG檢測試劑盒) were accredited as “Shenzhen independent innovation products (深圳市自主創新產品)” by the Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality (深圳市科技工貿和信息化委員會). Shenzhen Huakang was granted, for the first time, the status of “High and New Technology Enterprise” (國家高新技術企業) by the relevant governmental authorities in the PRC.

2012. We started the research and development of parasite antibody detection reagents.

2013. Our product spermatozoan surface antibody IgG mixed agglutination reaction kit (精子膜表面抗體IgG檢測試劑盒) was awarded Science and Technology Award of the Shenzhen Bao’an District (深圳市寶安區科學技術獎) by Shenzhen Municipal People’s Government (深圳市人民政府). Our parasite antibody detection reagent obtained the first product registration certificate from CFDA and was commercially launched in the PRC.

2014. One of our parasite antibody detection reagents is among the only two liver fluke IVD reagents which the CFDA has approved for manufacture and sale in the PRC.

2016. We moved to a new production plant at 1-3/F, Building D, Shenzhen Junxuan, 16 Yinkui Road, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, the PRC (中國深圳市大鵬新區葵涌辦事處葵新社區銀葵路16號君軒公司D棟廠房一至三層). We ranked the third among all manufacturers of male fertility IVD reagents in the PRC in terms of medical institution purchase value.

2017. Our Company was incorporated in the Cayman Islands.